Journal
MOLECULAR THERAPY-NUCLEIC ACIDS
Volume 17, Issue -, Pages 504-515Publisher
CELL PRESS
DOI: 10.1016/j.omtn.2019.05.020
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [81671919]
- Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai [PWZxq201710]
Ask authors/readers for more resources
Impaired wound healing is a debilitating complication of diabetes. The long non-coding RNA (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) has been recognized to be differentially expressed in various diseases. However, its underlying mechanism in diabetes has not been fully understood. Notably, we aim to examine the expression of MALAT1 in diabetic mice and its role in wound healing involving the hypoxia-inducible factor-1 alpha (HIF-1 alpha) signaling pathway with a modified autologous blood preservative solution reported. A mouse model of diabetes was established. MALAT1 was identified to promote the activation of the HIF-1 alpha signaling pathway and to be enriched in autologous blood through modified preservation, which might facilitate the improvement of physiological function of blood cells. Through gain- or loss-of-function approaches, viability of fibroblasts cultured in high glucose, wound healing of mice, and collagen expression in wound areas were enhanced by MALAT1 and HIF-1 alpha. Taken together, the present study demonstrated that the physiological status of mouse blood was effectively improved by modified autologous blood preservation, which exhibited upregulated MALAT1, thereby accelerating the fibroblast activation and wound healing in diabetic mice via the activation of the HIF-1 alpha signaling pathway. The upregulation of MALAT1 activating the HIF-1 alpha signaling pathway provides a novel insight into drug targets against diabetes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available